|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.689
|
Zebrafish Mouse |
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.404
|
Zebrafish Mouse |
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.350
|
Mouse |
|
|
muscle cell development
|
GO:0055001 |
133 |
0.321
|
Zebrafish Mouse |
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.308
|
Mouse |
|
|
sarcomere organization
|
GO:0045214 |
24 |
0.298
|
Zebrafish |
|
|
lens development in camera type eye
|
GO:0002088 |
62 |
0.297
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.261
|
Zebrafish Mouse |
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.256
|
Zebrafish Mouse |
|
|
actin filament based movement
|
GO:0030048 |
23 |
0.251
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.230
|
Zebrafish Mouse |
|
|
blood circulation
|
GO:0008015 |
195 |
0.219
|
Zebrafish Mouse |
|
|
developmental maturation
|
GO:0021700 |
193 |
0.202
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.200
|
Zebrafish Mouse |
|
|
nephric duct formation
|
GO:0072179 |
4 |
0.194
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.188
|
|
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.187
|
Zebrafish Mouse |
|
|
renal vesicle induction
|
GO:0072034 |
3 |
0.182
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.182
|
Zebrafish Mouse |
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.177
|
|
|
|
aortic valve morphogenesis
|
GO:0003180 |
4 |
0.177
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.173
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.161
|
Worm |
|
|
renal system development
|
GO:0072001 |
225 |
0.161
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.161
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.159
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.157
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.150
|
Mouse |
|
|
muscle system process
|
GO:0003012 |
141 |
0.147
|
Mouse Worm |
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.141
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.139
|
Zebrafish Mouse |
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.137
|
|
|
|
septum primum development
|
GO:0003284 |
4 |
0.136
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.136
|
Zebrafish Mouse |
|
|
ventricular cardiac myofibril assembly
|
GO:0055005 |
3 |
0.134
|
Zebrafish |
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.132
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.128
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.127
|
Zebrafish Mouse |
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.124
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.120
|
Zebrafish Mouse |
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.119
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.117
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.114
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.112
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.112
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.110
|
|
|
|
mitral valve morphogenesis
|
GO:0003183 |
4 |
0.109
|
|
|
|
paraxial mesodermal cell differentiation
|
GO:0048342 |
2 |
0.108
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.107
|
|
|
|
myosin filament organization
|
GO:0031033 |
3 |
0.106
|
|
|
|
positive regulation of interleukin 8 secretion
|
GO:2000484 |
1 |
0.106
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.106
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.105
|
Zebrafish |
|
|
potassium ion homeostasis
|
GO:0055075 |
4 |
0.104
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.102
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.102
|
|
|
|
endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:0003199 |
4 |
0.100
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.100
|
Mouse |
|
|
myosin filament assembly
|
GO:0031034 |
2 |
0.100
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.099
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.098
|
|
|
|
skeletal muscle thin filament assembly
|
GO:0030240 |
2 |
0.097
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.095
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.093
|
|
|
|
cardiac muscle fiber development
|
GO:0048739 |
4 |
0.092
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.092
|
Zebrafish Mouse |
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.092
|
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
68 |
0.092
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.089
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.089
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.088
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.088
|
Zebrafish Mouse |
|
|
hemostasis
|
GO:0007599 |
78 |
0.087
|
|
|
|
mesonephric duct morphogenesis
|
GO:0072180 |
4 |
0.086
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.085
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.085
|
|
|
|
ventricular cardiac muscle cell action potential
|
GO:0086005 |
4 |
0.085
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.085
|
|
|
|
regulation of ureteric bud formation
|
GO:0072106 |
3 |
0.084
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.083
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.083
|
Zebrafish Mouse |
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.082
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.082
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.082
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.081
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.081
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.081
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.081
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.080
|
|
|
|
paraxial mesodermal cell fate commitment
|
GO:0048343 |
2 |
0.080
|
|
|
|
mitral valve development
|
GO:0003174 |
4 |
0.079
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.079
|
|
|
|
myoblast differentiation involved in skeletal muscle regeneration
|
GO:0014835 |
3 |
0.079
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.079
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.079
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.078
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.078
|
|
|
|
positive regulation of ureteric bud formation
|
GO:0072107 |
3 |
0.078
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.078
|
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.077
|
|
|
|
pancreatic pp cell fate commitment
|
GO:0003329 |
2 |
0.077
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.077
|
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.077
|
|
|
|
pancreatic a cell fate commitment
|
GO:0003326 |
2 |
0.076
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.075
|
|
|
|
muscle adaptation
|
GO:0043500 |
39 |
0.075
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.075
|
|
|
|
atrial septum primum morphogenesis
|
GO:0003289 |
3 |
0.074
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.074
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.074
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.074
|
|
|
|
regulation of heart growth
|
GO:0060420 |
31 |
0.073
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.073
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.073
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.072
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.072
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.072
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.070
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.069
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.069
|
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.069
|
|
|
|
striated muscle myosin thick filament assembly
|
GO:0071688 |
1 |
0.069
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.069
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.068
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.068
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.068
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.067
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.066
|
|
|
|
muscle filament sliding
|
GO:0030049 |
1 |
0.066
|
|
|
|
positive regulation of cardioblast differentiation
|
GO:0051891 |
3 |
0.066
|
|
|
|
planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:0061348 |
2 |
0.065
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.065
|
|
|
|
embryonic heart tube development
|
GO:0035050 |
65 |
0.065
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.064
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.064
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.064
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.064
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.064
|
|
|
|
planar cell polarity pathway involved in pericardium morphogenesis
|
GO:0061354 |
2 |
0.064
|
|
|
|
embryonic heart tube morphogenesis
|
GO:0003143 |
51 |
0.064
|
|
|
|
positive regulation of secondary heart field cardioblast proliferation
|
GO:0072513 |
4 |
0.063
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.063
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.063
|
|
|
|
cardiac cell development
|
GO:0055006 |
41 |
0.062
|
Zebrafish Mouse |
|
|
hindbrain formation
|
GO:0021576 |
1 |
0.062
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.062
|
|
|
|
axis elongation involved in somitogenesis
|
GO:0090245 |
4 |
0.062
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.061
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.061
|
|
|
|
skeletal myofibril assembly
|
GO:0014866 |
4 |
0.061
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.061
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.060
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.060
|
|
|
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.060
|
Mouse |
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.060
|
|
|
|
clara cell differentiation
|
GO:0060486 |
4 |
0.060
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.060
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.060
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.060
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.059
|
|
|
|
myofibril assembly
|
GO:0030239 |
34 |
0.059
|
Zebrafish Mouse |
|
|
actin mediated cell contraction
|
GO:0070252 |
15 |
0.059
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.059
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.058
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.058
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.058
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.058
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.058
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.058
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.057
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.057
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.057
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.057
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.057
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.056
|
Zebrafish Worm |
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.056
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.055
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.055
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.055
|
|
|
|
positive regulation of auditory receptor cell differentiation
|
GO:0045609 |
1 |
0.055
|
|
|
|
myotube cell development
|
GO:0014904 |
60 |
0.055
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.055
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.054
|
|
|
|
mesonephric duct formation
|
GO:0072181 |
2 |
0.054
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.054
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.053
|
|
|
|
regulation of cell cell adhesion mediated by cadherin
|
GO:2000047 |
2 |
0.053
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.053
|
|
|
|
cardiac neural crest cell migration involved in outflow tract morphogenesis
|
GO:0003253 |
3 |
0.053
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.053
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.052
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.052
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.052
|
|
|
|
cardiac muscle cell contraction
|
GO:0086003 |
7 |
0.052
|
|
|
|
intestinal epithelial structure maintenance
|
GO:0060729 |
4 |
0.052
|
|
|
|
oxygen homeostasis
|
GO:0032364 |
2 |
0.052
|
|
|
|
planar cell polarity pathway involved in outflow tract morphogenesis
|
GO:0061347 |
2 |
0.052
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.052
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.051
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.051
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.051
|
|
|
|
positive regulation of epithelial cell proliferation involved in lung morphogenesis
|
GO:0060501 |
3 |
0.051
|
|
|
|
bundle of his development
|
GO:0003166 |
4 |
0.051
|
|
|
|
planar cell polarity pathway involved in cardiac muscle tissue morphogenesis
|
GO:0061350 |
2 |
0.051
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.051
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.050
|
|
|
|
branching involved in mammary gland duct morphogenesis
|
GO:0060444 |
27 |
0.050
|
|
|
|
planar cell polarity pathway involved in cardiac right atrium morphogenesis
|
GO:0061349 |
2 |
0.050
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.050
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.050
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.050
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.050
|
|
|
|
embryonic heart tube formation
|
GO:0003144 |
1 |
0.049
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.049
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.049
|
|
|
|
ureteric bud morphogenesis
|
GO:0060675 |
62 |
0.049
|
|
|
|
positive regulation of potassium ion transport
|
GO:0043268 |
3 |
0.049
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.049
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.049
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.049
|
|
|
|
wnt signaling pathway involved in forebrain neuroblast division
|
GO:0021874 |
2 |
0.048
|
|
|
|
positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:2000802 |
1 |
0.048
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.048
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.048
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.048
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.048
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.048
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.048
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.048
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.048
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.048
|
|
|
|
endocardial cushion development
|
GO:0003197 |
26 |
0.047
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.047
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.047
|
|
|
|
striated muscle adaptation
|
GO:0014888 |
26 |
0.047
|
|
|
|
determination of left right symmetry
|
GO:0007368 |
80 |
0.047
|
|
|
|
uterus morphogenesis
|
GO:0061038 |
2 |
0.047
|
|
|
|
wnt signaling pathway involved in kidney development
|
GO:0061289 |
2 |
0.046
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.046
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.046
|
|
|
|
negative regulation of cell growth
|
GO:0030308 |
44 |
0.046
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.046
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.046
|
|
|
|
hemangioblast cell differentiation
|
GO:0060217 |
1 |
0.046
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.046
|
|
|
|
interleukin 8 secretion
|
GO:0072606 |
3 |
0.046
|
|
|
|
regulation of intestinal epithelial structure maintenance
|
GO:0060730 |
1 |
0.046
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.046
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.046
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.046
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.046
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.046
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.046
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.045
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.045
|
|
|
|
central nervous system vasculogenesis
|
GO:0022009 |
3 |
0.045
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.045
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.044
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.044
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.044
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.044
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.044
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.044
|
|
|
|
positive regulation of transforming growth factor beta2 production
|
GO:0032915 |
2 |
0.044
|
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.044
|
|
|
|
regulation of neural retina development
|
GO:0061074 |
3 |
0.044
|
|
|
|
regulation of jnk cascade
|
GO:0046328 |
62 |
0.044
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.044
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.043
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.043
|
|
|
|
pancreas development
|
GO:0031016 |
57 |
0.043
|
|
|
|
regulation of interleukin 8 secretion
|
GO:2000482 |
2 |
0.043
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.043
|
|
|
|
skeletal muscle adaptation
|
GO:0043501 |
16 |
0.043
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.043
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.043
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.043
|
Mouse Worm |
|
|
positive regulation of branching involved in lung morphogenesis
|
GO:0061047 |
4 |
0.043
|
|
|
|
spemann organizer formation
|
GO:0060061 |
2 |
0.043
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.043
|
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.043
|
|
|
|
mesonephric tubule morphogenesis
|
GO:0072171 |
63 |
0.042
|
|
|
|
auditory receptor cell fate determination
|
GO:0042668 |
3 |
0.042
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.042
|
|
|
|
regulation of cardiac muscle cell proliferation
|
GO:0060043 |
23 |
0.042
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.042
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.042
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.042
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.042
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in norepinephrine biosynthetic process
|
GO:2000763 |
1 |
0.042
|
|
|
|
negative regulation of ossification
|
GO:0030279 |
49 |
0.042
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.042
|
|
|
|
determination of heart left right asymmetry
|
GO:0061371 |
48 |
0.041
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.041
|
|
|
|
mesoderm morphogenesis
|
GO:0048332 |
64 |
0.041
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.041
|
|
|
|
semaphorin plexin signaling pathway involved in outflow tract morphogenesis
|
GO:0071527 |
1 |
0.041
|
|
|
|
branching involved in ureteric bud morphogenesis
|
GO:0001658 |
56 |
0.041
|
|
|
|
regulation of cardioblast differentiation
|
GO:0051890 |
3 |
0.041
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.041
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.040
|
|
|
|
outflow tract morphogenesis
|
GO:0003151 |
53 |
0.040
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.040
|
|
|
|
atrial ventricular junction remodeling
|
GO:0003294 |
2 |
0.040
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.040
|
|
|
|
regulation of skeletal muscle fiber development
|
GO:0048742 |
36 |
0.040
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.040
|
|
|
|
regulation of renin secretion into blood stream
|
GO:1900133 |
4 |
0.040
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.040
|
|
|
|
ventricular septum morphogenesis
|
GO:0060412 |
27 |
0.040
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in myocardial precursor cell differentiation
|
GO:0003257 |
3 |
0.040
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.040
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.039
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.039
|
|
|
|
platelet morphogenesis
|
GO:0036344 |
13 |
0.039
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.039
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.039
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.039
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.039
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.039
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.039
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.039
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.039
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.039
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.039
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.039
|
|
|
|
central nervous system morphogenesis
|
GO:0021551 |
2 |
0.039
|
|
|
|
cell proliferation involved in outflow tract morphogenesis
|
GO:0061325 |
4 |
0.039
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.039
|
|
|
|
closure of optic fissure
|
GO:0061386 |
2 |
0.038
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.038
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.038
|
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
62 |
0.038
|
|
|
|
regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:2000800 |
1 |
0.038
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.038
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.038
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.038
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.038
|
|
|
|
trachea cartilage morphogenesis
|
GO:0060535 |
4 |
0.038
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.038
|
|
|
|
regulation of organ growth
|
GO:0046620 |
61 |
0.037
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.037
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.037
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.037
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.037
|
|
|
|
regulation of auditory receptor cell differentiation
|
GO:0045607 |
4 |
0.037
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.037
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.036
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.036
|
|
|
|
endocrine pancreas development
|
GO:0031018 |
29 |
0.036
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.036
|
|
|
|
regulation of anagen
|
GO:0051884 |
1 |
0.036
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.036
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.036
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.036
|
|
|
|
regulation of atp catabolic process
|
GO:1903289 |
9 |
0.036
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.036
|
|
|
|
ubiquitin dependent smad protein catabolic process
|
GO:0030579 |
2 |
0.036
|
|
|
|
ventricular septum development
|
GO:0003281 |
42 |
0.035
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.035
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.035
|
|
|
|
gas homeostasis
|
GO:0033483 |
3 |
0.035
|
|
|
|
potassium ion transport
|
GO:0006813 |
52 |
0.035
|
|
|
|
endodermal cell fate determination
|
GO:0007493 |
2 |
0.035
|
|
|
|
humoral immune response
|
GO:0006959 |
57 |
0.035
|
|
|
|
antimicrobial peptide production
|
GO:0002775 |
2 |
0.035
|
|
|
|
regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation
|
GO:2000702 |
1 |
0.035
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.035
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.035
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.035
|
|
|
|
pancreatic pp cell differentiation
|
GO:0003312 |
2 |
0.034
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.034
|
|
|
|
blastocyst formation
|
GO:0001825 |
33 |
0.034
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.034
|
|
|
|
regulation of mast cell differentiation
|
GO:0060375 |
3 |
0.034
|
|
|
|
endocardial cushion morphogenesis
|
GO:0003203 |
18 |
0.034
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.034
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.034
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.034
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.033
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.033
|
|
|
|
immune response activating cell surface receptor signaling pathway
|
GO:0002429 |
72 |
0.033
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.033
|
|
|
|
nephron tubule formation
|
GO:0072079 |
20 |
0.033
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.033
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.033
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.033
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.033
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.033
|
|
|
|
negative regulation of alcohol biosynthetic process
|
GO:1902931 |
4 |
0.033
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.033
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.033
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.033
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.033
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.033
|
|
|
|
regulation of kidney development
|
GO:0090183 |
40 |
0.033
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.032
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.032
|
|
|
|
cell communication by electrical coupling involved in cardiac conduction
|
GO:0086064 |
2 |
0.032
|
|
|
|
negative regulation of potassium ion transmembrane transporter activity
|
GO:1901017 |
3 |
0.032
|
|
|
|
ureter development
|
GO:0072189 |
12 |
0.032
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.032
|
|
|
|
autonomic nervous system development
|
GO:0048483 |
43 |
0.032
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.032
|
|
|
|
regulation of rho gtpase activity
|
GO:0032319 |
58 |
0.032
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.032
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.032
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.032
|
|
|
|
regulation of muscle contraction
|
GO:0006937 |
49 |
0.032
|
Worm |
|
|
sclerotome development
|
GO:0061056 |
4 |
0.032
|
|
|
|
regulation of protein stability
|
GO:0031647 |
52 |
0.032
|
|
|
|
positive regulation of potassium ion transmembrane transport
|
GO:1901381 |
3 |
0.031
|
|
|
|
thyroid stimulating hormone secreting cell differentiation
|
GO:0060129 |
4 |
0.031
|
|
|
|
embryonic forelimb morphogenesis
|
GO:0035115 |
32 |
0.031
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.031
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.031
|
|
|
|
regulation of ventricular cardiac muscle cell membrane depolarization
|
GO:0060373 |
2 |
0.031
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.031
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.031
|
|
|
|
regulation of testosterone biosynthetic process
|
GO:2000224 |
2 |
0.031
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.031
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.031
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.031
|
|
|
|
inositol lipid mediated signaling
|
GO:0048017 |
41 |
0.031
|
|
|
|
renal inner medulla development
|
GO:0072053 |
3 |
0.031
|
|
|
|
regulation of sarcomere organization
|
GO:0060297 |
4 |
0.031
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.031
|
|
|
|
antigen receptor mediated signaling pathway
|
GO:0050851 |
64 |
0.031
|
|
|
|
forelimb morphogenesis
|
GO:0035136 |
40 |
0.031
|
|
|
|
sa node cell action potential
|
GO:0086015 |
4 |
0.031
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.031
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.031
|
|
|
|
lung alveolus development
|
GO:0048286 |
45 |
0.031
|
|
|
|
palate development
|
GO:0060021 |
76 |
0.031
|
|
|
|
visceral serous pericardium development
|
GO:0061032 |
2 |
0.031
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.031
|
|
|
|
non canonical wnt signaling pathway via jnk cascade
|
GO:0038031 |
3 |
0.030
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.030
|
|
|
|
his purkinje system development
|
GO:0003164 |
4 |
0.030
|
|
|
|
cardiac muscle hypertrophy in response to stress
|
GO:0014898 |
10 |
0.030
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.030
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.030
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.030
|
|
|
|
positive regulation of semaphorin plexin signaling pathway involved in outflow tract morphogenesis
|
GO:2000764 |
1 |
0.030
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.030
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.030
|
|
|
|
cerebellum formation
|
GO:0021588 |
1 |
0.030
|
|
|
|
regulation of skeletal muscle adaptation
|
GO:0014733 |
12 |
0.030
|
|
|
|
response to parathyroid hormone
|
GO:0071107 |
3 |
0.030
|
|
|
|
regulation of heart rate
|
GO:0002027 |
36 |
0.030
|
|
|
|
lens morphogenesis in camera type eye
|
GO:0002089 |
24 |
0.030
|
|
|
|
artery development
|
GO:0060840 |
53 |
0.030
|
|
|
|
cell proliferation involved in heart valve development
|
GO:2000793 |
2 |
0.029
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.029
|
|
|
|
potassium ion transmembrane transport
|
GO:0071805 |
43 |
0.029
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.029
|
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
50 |
0.029
|
|
|
|
cardiac right ventricle formation
|
GO:0003219 |
3 |
0.029
|
|
|
|
mesenchymal cell proliferation involved in ureter development
|
GO:0072198 |
4 |
0.029
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.029
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.029
|
|
|
|
embryonic heart tube anterior posterior pattern specification
|
GO:0035054 |
3 |
0.029
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.029
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.029
|
|
|
|
response to retinoic acid
|
GO:0032526 |
56 |
0.029
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.029
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.029
|
|
|
|
midbrain hindbrain boundary maturation during brain development
|
GO:0022004 |
1 |
0.029
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.029
|
|
|
|
regulation of morphogenesis of a branching structure
|
GO:0060688 |
53 |
0.029
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
47 |
0.029
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.029
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.029
|
|
|
|
spemann organizer formation at the anterior end of the primitive streak
|
GO:0060064 |
1 |
0.029
|
|
|
|
sinoatrial node cell differentiation
|
GO:0060921 |
3 |
0.028
|
|
|
|
lung epithelium development
|
GO:0060428 |
37 |
0.028
|
|
|
|
cell migration involved in gastrulation
|
GO:0042074 |
13 |
0.028
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.028
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.028
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.028
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.028
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.028
|
|
|
|
positive regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045899 |
2 |
0.028
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.028
|
|
|
|
outer medullary collecting duct development
|
GO:0072060 |
1 |
0.028
|
|
